Skip to main content
. 2021 Feb 12;12:637910. doi: 10.3389/fimmu.2021.637910

Figure 1.

Figure 1

Three possible scenarios in the equilibrium between drug toxicity and damage from HIV-related immune activation: (A) A perfect balance between these factors with the smallest possible risk for comorbidity. (B) The reduction in the number of antiretroviral drugs diminishes the risk for drug toxicity but a flare in immune activation could lead to HIV-associated comorbidity. (C) Multiple antiretroviral drugs are able to fully suppress the virus but this poses a significant risk for cART-associated toxicity.